CleanSpace Holdings Limited (CSX.AX)
AUD 0.41
(2.5%)
AUD 0.41
(2.5%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -3.49 Million AUD | 66.89% |
| 2023 | -10.54 Million AUD | 23.4% |
| 2022 | -13.99 Million AUD | -182.33% |
| 2021 | 17.14 Million AUD | 141.08% |
| 2020 | 7.03 Million AUD | 548.94% |
| 2019 | -1.65 Million AUD | 22.52% |
| 2018 | -2.04 Million AUD | -12.26% |
| 2017 | -1.82 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -836.73 Thousand AUD | 0.0% |
| 2024 Q1 | -1.32 Million AUD | 68.51% |
| 2024 FY | - AUD | 64.98% |
| 2024 Q2 | -2.65 Million AUD | -83.33% |
| 2024 Q3 | -836.73 Thousand AUD | 65.67% |
| 2023 Q4 | -4.22 Million AUD | -79.46% |
| 2023 FY | - AUD | 23.4% |
| 2023 Q3 | -2.35 Million AUD | 64.17% |
| 2023 Q2 | -6.56 Million AUD | -100.0% |
| 2023 Q1 | -3.28 Million AUD | 54.87% |
| 2022 Q4 | -7.27 Million AUD | -87.47% |
| 2022 Q1 | -3.4 Million AUD | -67.25% |
| 2022 FY | - AUD | -182.33% |
| 2022 Q3 | -3.88 Million AUD | 43.17% |
| 2022 Q2 | -6.82 Million AUD | -100.25% |
| 2021 Q1 | 9.56 Million AUD | 13.35% |
| 2021 Q4 | -2.03 Million AUD | -112.19% |
| 2021 Q3 | -960.82 Thousand AUD | -105.03% |
| 2021 Q2 | 19.08 Million AUD | 99.51% |
| 2021 FY | - AUD | 141.08% |
| 2020 Q4 | 8.44 Million AUD | 95.4% |
| 2020 Q2 | -1.04 Million AUD | -100.99% |
| 2020 FY | - AUD | 548.94% |
| 2020 Q1 | -519.2 Thousand AUD | 0.0% |
| 2020 Q3 | 4.31 Million AUD | 513.95% |
| 2019 FY | - AUD | 22.52% |
| 2018 FY | - AUD | -12.26% |
| 2017 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 90.318% |
| Adherium Limited | -11.56 Million AUD | 69.806% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 52.558% |
| Atomo Diagnostics Limited | -5.42 Million AUD | 35.617% |
| Anteris Technologies Ltd | -66.9 Million AUD | 94.781% |
| Control Bionics Limited | -5.15 Million AUD | 32.306% |
| CardieX Limited | -6.71 Million AUD | 47.976% |
| Compumedics Limited | 2.78 Million AUD | 225.199% |
| Cochlear Limited | 579.5 Million AUD | 100.603% |
| Cyclopharm Limited | -3.03 Million AUD | -15.055% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -66.975% |
| Nova Eye Medical Limited | -5.97 Million AUD | 41.599% |
| HeraMED Limited | -3.97 Million AUD | 12.091% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 84.034% |
| ImpediMed Limited | -22.05 Million AUD | 84.165% |
| InhaleRx Limited | -1.41 Million AUD | -146.99% |
| LBT Innovations Limited | -4.04 Million AUD | 13.761% |
| Micro-X Limited | -14.35 Million AUD | 75.669% |
| Neurotech International Limited | -8.24 Million AUD | 57.644% |
| OncoSil Medical Limited | -11.97 Million AUD | 70.844% |
| PolyNovo Limited | 5.17 Million AUD | 167.54% |
| Respiri Limited | -7.04 Million AUD | 50.47% |
| SomnoMed Limited | -2.32 Million AUD | -49.952% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 61.588% |
| Uscom Limited | -1.5 Million AUD | -131.351% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | 28.991% |